The case for global gender-neutral HPV vaccination
Prof Richard Sullivan talks about a collaborative initiative to push the issue of cancer and the elderly up the social-political agenda. He suggests reasons for why older patients receive inadequate treatment and what needs to be done to improve the situation.
This interview is supported by an unrestricted educational grant from Celgene.
Click on the links below to see more from Prof Richard Sullivan:
Prof. Sullivan participates in a roundtable discussion about the treatment of elderly cancer patients.
Prof. Sullivan talks about innovation in cancer drug development.
Prof. Sullivan discusses UK cancer reform strategy.
Prof. Sullivan speaks about prioritisation in cancer research.
A presentation from Prof. Sullivan about cancer research priorities.
The case for global gender-neutral HPV vaccination
Boosting HPV vaccination in India: A call to action
Legislation – a powerful tool for promoting massive changes
Gaza's cancer patients: Navigating the dual struggle of illness and war
Tackling breast cancer screening in conservative communities
Cancer in emergencies: What can we do better to protect the most vulnerable?
Tele-mentoring: Impact of project ECHO
Exploring Common Sense Oncology (CSO) and Patient-Centric research
Navigating cancer treatment choices